WARSAW, Ind., Aug. 26 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. , a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today the appointment of Ronda Harris to Chief Accounting Officer, effective September 1, 2008.
Ms. Harris will assume responsibility for Symmetry’s consolidated financials, external reporting and standardizing global accounting. She will also provide direct controllership support, and will report directly to Fred Hite, Senior Vice President and Chief Financial Officer.
Ms. Harris is a seasoned executive with extensive experience in financial management. She has held leadership roles in planning and implementation of effective financial reporting and financial control processes. Prior to joining Symmetry, Ms. Harris served as Assistant Controller of General Electric’s Consumer and Industrial Business, where she was instrumental in integrating General Electric’s $13 billion business onto a common financial platform, implementing unified processes and accounting policies. Prior to General Electric, Ms. Harris began her career at Pricewaterhouse Coopers. She received a Bachelor of Science degree from Indiana University.
Brian Moore, President and Chief Executive Officer, stated, “We are pleased to announce an excellent addition to our financial management team with Ronda’s appointment to Chief Accounting Officer. Ms. Harris adds strong leadership skills and a proven track record in financial management to our already outstanding financial team. We believe her extensive experience and accounting expertise will make major contributions to Symmetry’s financial and operating infrastructure.”
About Symmetry Medical Inc.
Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopaedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.
Forward-Looking Statements
Statements in the press release regarding Symmetry Medical Inc.'s business, which are not historical facts, may be “forward-looking statements” that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as “may,” “might,” “will,” “should,” “expect,” “believe,” “anticipate,” “plan,” “estimate,” “intend,” and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual outcomes and results could differ materially from our current expectations. We refer you to the “Risk Factors” and “Forward Looking-Statements” sections in the Company’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as the Company’s other filings with the SEC, which are available on the SEC’s Web site at www.sec.gov.
CONTACT: Investors-Media: Nick Laudico, +1-646-536-7030,
nlaudico@theruthgroup.com, or Jason Rando, +1-646-536-7025,
jrando@theruthgroup.com; or Fred L. Hite, Senior Vice President, Chief
Financial Officer of Symmetry Medical Inc., +1-574-371-2218
